Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Molecular Cancer Therapeutics|July 5, 2019
Anti-GPRC5D/CD3 Bispecific T-Cell-Redirecting Antibody for the Treatment of Multiple MyelomaTatsushi Kodama, Yu Kochi, Waka Nakai, et al.
Gastroenterology|December 14, 2005
A new method for isolating colonocytes from naturally evacuated feces and its clinical application to colorectal cancer diagnosisHisayuki Matsushita, Yasuhiro Matsumura, Yoshihiro Moriya, et al.
Blood|September 18, 2004
A novel therapeutic approach for thrombocytopenia by minibody agonist of the thrombopoietin receptorTetsuro Orita, Hiroyuki Tsunoda, Naohiro Yabuta, et al.
Cancer Science|August 22, 2023
Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancerShuichi Mitsunaga, Masafumi Ikeda, Hiroshi Imaoka, et al.
Cancer Research|April 3, 2004
Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinomaYoshitaka Hippo, Kiyotaka Watanabe, Akira Watanabe, et al.
Cancer Immunology Research|July 8, 2025
EML4-ALK Rearrangement Creates a Distinctive Myeloid Cell-Dominant Immunosuppressive Microenvironment in Lung CancerKosuke Arai, Yukari Nishito, Hideaki Mizuno, et al.
Cancer Letters|February 21, 2026
MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinomaHironori Fukuda, Kosuke Arai, Eri Hashimoto, et al.
Nature Medicine|October 2, 2012
A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A modelTakehisa Kitazawa, Tomoyuki Igawa, Zenjiro Sampei, et al.
Cancer Research Communications|June 28, 2023
Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic AlterationsKazunori Aoki, Yukari Nishito, Noriko Motoi, et al.
Pageof 4